Open Access and Peer-reviewed
Home Journal Issues Guide for Authors Editorial Board Aims & Scope About Journal News & Announcements


Review Article 
RMJ. 2021; 46(1): 240-244


A Systematic Review of pharmacological efficacy and alternative treatments for the prevention of ultra-high risk for psychosis

Bong Ju Lee.

Abstract
Objective: To present and evaluate the latest findings of studies pertaining to the pharmacological and alternative treatment of individuals at ultra-high risk (UHR) for psychosis.
Methodology: A title or abstract appeared to describe a study eligible for inclusion; the full article was obtained and examined to assess its relevance. The PUBMED search terms in the title used were “psychosis,” “schizophrenia,” "ultra-high risk," "clinical high risk," "at risk mental state," “intervention,” “efficacy,” “effectiveness,” “management,” “treatment,” and “prevention.” The combined search strategies yielded over 100 abstracts but, after an analysis of the abstracts, 97 full-text articles were reviewed. Finally, 35 articles were included.
Results: Antipsychotics that have been tried to date are amisulpride, aripiprazole, olanzapine, perospirone, risperidone, and ziprasidone. Although most studies included small groups, the baseline symptoms improved after pharmacological treatment. However, the antipsychotic effect of treatment with antipsychotics in UHR groups was insufficient to confirm positive results. In the long-term follow-up of UHR groups, more than 30% of studied individuals remained in the high-risk group and had clinically significant symptoms and difficulties.
Conclusion: If antipsychotics are to be used, atypical antipsychotics should be selected; starting with a low dose, and the treatment response and side effects should be periodically evaluated, while administration should last for an appropriately limited period of time. In addition to antipsychotics, use of antidepressants, nutrients/supplements including omega-3, and alternative drugs should be considered.

Key words: Psychosis, psychiatric symptoms, alternative treatments.


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Bong Ju Lee
on Google
on Google Scholar


How to Cite this Article
Pubmed Style

Bong Ju Lee. A Systematic Review of pharmacological efficacy and alternative treatments for the prevention of ultra-high risk for psychosis.


Web Style

Bong Ju Lee. A Systematic Review of pharmacological efficacy and alternative treatments for the prevention of ultra-high risk for psychosis. http://www.rmj.org.pk/?mno=10228 [Access: March 17, 2021].


AMA (American Medical Association) Style

Bong Ju Lee. A Systematic Review of pharmacological efficacy and alternative treatments for the prevention of ultra-high risk for psychosis.



Vancouver/ICMJE Style

Bong Ju Lee. A Systematic Review of pharmacological efficacy and alternative treatments for the prevention of ultra-high risk for psychosis.



Harvard Style

Bong Ju Lee (2021) A Systematic Review of pharmacological efficacy and alternative treatments for the prevention of ultra-high risk for psychosis.



Turabian Style

Bong Ju Lee. 2021. A Systematic Review of pharmacological efficacy and alternative treatments for the prevention of ultra-high risk for psychosis.



Chicago Style

Bong Ju Lee. "A Systematic Review of pharmacological efficacy and alternative treatments for the prevention of ultra-high risk for psychosis."



MLA (The Modern Language Association) Style

Bong Ju Lee. "A Systematic Review of pharmacological efficacy and alternative treatments for the prevention of ultra-high risk for psychosis."



APA (American Psychological Association) Style

Bong Ju Lee (2021) A Systematic Review of pharmacological efficacy and alternative treatments for the prevention of ultra-high risk for psychosis.








AUTHOR LOGIN

REVIEWER LOGIN

Indexed
&
Abstracted


Indexed in WHO Index Medicus IMEMR, Emromedex, Pakmedinet, ExtraMED,  Scopus and Web of Science

                     Approved by the Higher Education Commission of Pakistan 


ABOUT JOURNAL
POLICIES
STATEMENTS

This is an open access journal which means that all content is freely available without charge to the user or his/her institution. Users are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles in this journal without asking prior permission from the publisher or the author. This is in accordance with the Budapest Open Access Initiative (BOAI) definition of open access.

The articles in Rawal Medical Journal are open access articles licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc-sa/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.